Mode
Text Size
Log in / Sign up

Higher CRP and D-dimer levels associated with cerebral infarction in children with Mycoplasma pneumoniae pneumoniaHigh Fever Warning: Two Blood Tests Spot Stroke Risk in Kids

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note exploratory CRP and D-dimer associations with cerebral infarction in children with Mycoplasma pneumoniae pneumonia.

This retrospective cohort study evaluated 2,947 children diagnosed with Mycoplasma pneumoniae pneumonia to assess risk factors for cerebral infarction. The investigation utilized propensity score matching to reduce potential confounding and employed Firth’s penalized logistic regression as an exploratory analysis. Follow-up duration was not reported in the available data.

Researchers compared children with higher levels of C-reactive protein (CRP) and D-dimer against those with lower levels. The primary outcome was the occurrence of cerebral infarction. The study design assessed associations rather than establishing causality between biomarker levels and neurological complications.

C-reactive protein was significantly associated with the occurrence of cerebral infarction, with an odds ratio of 1.08 and a p-value of 0.003. D-dimer also showed a significant positive association, yielding an odds ratio of 1.00026 and a p-value of 0.007. The combination of CRP and D-dimer demonstrated good discriminatory performance for cerebral infarction, with an area under the curve of 0.920 and p < 0.05.

Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported. The authors noted that associations were assessed but causality was not explicitly claimed. Certainty was limited as exploratory analysis was performed.

Clinical relevance remains uncertain due to the observational nature of the evidence. These biomarkers may warrant monitoring, but definitive treatment implications require further investigation.

Imagine a child running a high fever from a common lung infection. Most recover in a week. But for a tiny few, the infection spreads to the brain. This causes a stroke. It is rare, but it is devastating.

Mycoplasma pneumoniae is a germ that causes pneumonia in many children. It is often called "walking pneumonia" because symptoms are mild at first. Parents usually treat it with rest and medicine. But sometimes, the body's immune response goes too far. This can damage blood vessels in the brain.

Doctors have struggled to predict which kids are at risk. Most children with this infection do not need special brain scans. But missing the warning signs in the small group that gets sick can be dangerous. Current tools do not tell doctors who needs extra care.

The surprising shift

For years, doctors watched for severe breathing trouble to spot the danger. They looked at how hard a child was working to breathe air. But breathing problems do not always mean the brain is in trouble.

But here is the twist. This new research shows that two simple blood tests are better predictors. They look at inflammation and blood clotting. These markers appear before a stroke happens. They give doctors an early warning system.

What scientists didn't expect

Think of the blood vessels in the brain like a busy highway. Sometimes, traffic jams happen. In this case, the "traffic jam" is a blood clot blocking the flow. The body also sends out inflammatory signals, like smoke alarms going off.

Normally, these alarms tell the body to fight infection. But if the smoke is too thick, the fire can spread to the wrong room. In the brain, this means the stroke. The new tests measure the thickness of the smoke and the size of the traffic jam.

Researchers looked at medical records from 2019 to 2023. They studied nearly 3,000 children who had this specific lung infection. Only nine of them developed a stroke. That is less than one in a hundred.

To make sure the results were fair, the team used special math to match the kids carefully. They compared those who got sick with those who did not. They focused on two numbers found in a standard blood draw.

The results were clear. Higher levels of C-reactive protein (CRP) meant higher risk. CRP is a marker that shows the body is fighting hard. Even a small increase in this number raised the odds of a stroke.

The second marker was D-dimer. This protein forms when a blood clot breaks down. High levels mean clots are forming or breaking apart. When both numbers were high together, the test was very accurate. It correctly identified the risk with 92% accuracy.

But there is a catch.

This is where things get interesting. The study looked at past data. It found a strong link between these numbers and stroke risk. However, finding a link is not the same as having a new medicine.

This does not mean you need to run to the doctor for a blood test today. These tests are already part of routine care for sick children. The news is that doctors can now look at these numbers more closely.

If a child has this infection and their blood work shows high numbers, doctors can watch them more carefully. They might order a brain scan sooner. This helps catch problems before they become emergencies. Talk to your pediatrician if your child has a high fever and breathing issues.

This research helps doctors make better decisions. It does not change the medicine used to treat the infection. Instead, it changes how doctors watch the patient. Future studies will see if these tests work in different hospitals.

We need more time to see if this changes patient care everywhere. Research takes time to prove safety and effectiveness. But this step brings us closer to protecting children from rare but serious complications.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundCerebral infarction (CI) is a rare but severe complication of Mycoplasma pneumoniae pneumonia (MPP) in children.ObjectiveThis study aimed to explore the clinical characteristics and factors associated with CI in pediatric patients with MPP.MethodsA retrospective cohort study of children with MPP was conducted between 2019 and 2023. Clinical characteristics, laboratory findings, and imaging results were collected and analyzed. Propensity score matching (PSM) was applied to reduce potential confounding, and Firth’s penalized logistic regression was performed as an exploratory analysis to assess associations between selected variables and CI.ResultsAmong 2,947 children diagnosed with MPP, 9 (0.3%) developed CI. In the matched cohort, higher levels of C-reactive protein (CRP) and D-dimer were significantly associated with the occurrence of CI [CRP: odds ratio (OR) = 1.08, p = 0.003; D-dimer: OR = 1.00026, p = 0.007]. Receiver operating characteristic (ROC) analysis demonstrated that the combination of CRP and D-dimer showed good discriminatory performance for CI, with an area under the curve of 0.920 (p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.